查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1426466

2024 年染色質免疫沉澱 (ChIP)定序全球市場報告

Chromatin immunoprecipitation (ChIP) Sequencing Global Market Report 2024
出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

染色質免疫沉澱（ChIP）定序的市場規模預計在未來幾年將快速成長。預計到 2028 年將以 12.5% 的複合年成長率 (CAGR) 成長至 222.6 億美元。預測期內的預期成長是由產業投資和競爭增加、診斷應用的臨床採用增加、生物標記發現的需求、生物資訊工具的快速發展以及使用染色質免疫沉澱(ChIP) 定序的染色質免疫沉澱(ChIP)定序的。可能是由於藥物發現應用的擴展。預測期內預計的主要趨勢包括 ChIP定序在臨床和診斷應用中的應用、對組蛋白修飾的更多關注、在新研究領域的應用、樣品製備技術的進步以及多組體學的發展。例子包括整合。

染色質免疫沉澱 (ChIP)定序市場的成長預計將受到攝護腺癌盛行率不斷上升的推動。發生在前列腺中的前列腺癌預計將有助於市場擴張。 ChIP-seq 透過提供對影響前列腺癌的分子事件的全面了解，在前列腺癌研究中發揮重要作用。這些資訊對於增進我們對其生物學的理解和開發更有針對性的治療性介入至關重要。 2023年1月，美國癌症協會報告稱，美國估計有288,300例前列腺癌新病例和34,700例死亡，ChIP-我們強調了seq的重要性。

個人化醫療的日益普及預計將推動染色質免疫沉澱 (ChIP)定序市場的成長。個人化醫療根據個別患者的特徵量身訂做醫療決策，並依賴識別與疾病相關的特定遺傳或磊晶標記。 ChIP 定序已被證明是繪製磊晶修飾圖譜的強大工具，這對於了解疾病的遺傳基礎非常重要。 2022年，FDA藥物評估與研究中心核准了37個新分子實體，其中34%被個人化醫療聯盟指定用於個人化醫療，以及染色質免疫沉澱（ChIP）定序在個人化醫療進展中的作用。該定序的突出顯示。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球市場促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 2018-2023 年全球市場規模表現與成長
  • 全球市場規模預測與成長，2023-2028、2033

第6章市場區隔

  • 全球染色質免疫沉澱 (ChIP)定序市場，按類型細分、實際和預測，2018-2023、2023-2028、2033
  • 脫氧核糖核酸酶序列
  • 公平序列
  • 全球染色質免疫沉澱 (ChIP)定序市場，按技術、性能和預測細分，2018-2023、2023-2028、2033
  • 標靶定序和定序
  • 全基因組定序和全EXOME定序
  • 全球染色質免疫沉澱 (ChIP)定序市場，依工作流程、效能和預測細分，2018-2023、2023-2028、2033
  • 前序
  • 順序
  • 資料分析
  • 全球染色質免疫沉澱 (ChIP)定序市場，按應用、性能和預測細分，2018-2023、2023-2028、2033
  • 耗材和試劑
  • 服務
  • 其他用途
  • 全球染色質免疫沉澱 (ChIP)定序市場，依最終用戶細分、性能和預測，2018-2023、2023-2028、2033
  • 學術研究所
  • 臨床研究所
  • 醫院和診所
  • 製藥和生物技術公司
  • 其他最終用戶

第 7 章 區域與國家分析

  • 全球染色質免疫沉澱 (ChIP)定序市場，按地區、績效和預測，2018-2023、2023-2028、2033
  • 全球染色質免疫沉澱 (ChIP)定序市場，按國家/地區、績效和預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭形勢及公司概況

  • 染色質免疫沉澱（ChIP）定序市場的競爭形勢
  • 染色質免疫沉澱（ChIP）定序市場公司概況
    • F. Hoffmann La Roche Ltd.
    • Merck KGaA
    • Thermo Fisher Scientific Inc.
    • Becton Dickinson and Co.
    • Eurofins Scientific SE

第31章 其他大型創新公司

  • Agilent Technologies Inc.
  • Illumina Inc.
  • PerkinElmer Inc.
  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • Bio-Techne Corp.
  • BGI Genomics Co. Ltd.
  • Promega Corporation
  • GenScript Biotech Corporation
  • Abcam plc
  • BioLegend Inc.
  • Hamilton Co.
  • Takara Bio Inc.
  • Novogene Co. Ltd.
  • Oxford Nanopore Technologies plc

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來前景與可能性分析

第36章附錄

簡介目錄
Product Code: r13478

Chromatin immunoprecipitation (ChIP) sequencing is a powerful molecular biology technique employed to investigate the interactions between proteins and DNA within a cell, offering insights into the binding patterns of specific proteins, often transcription factors or other chromatin-associated proteins, to DNA in a genome-wide manner.

The main types of ChIP sequencing include DNase-sequencing and Faire-sequencing. DNase-sequencing, commonly known as DNase-seq, is a molecular biology technique designed to assess the accessibility of DNA within the genome. It utilizes various technologies such as targeted sequencing, re-sequencing, whole genome sequencing, and whole exome sequencing for pre-sequencing, sequencing, and data analysis. The applications of DNase-seq encompass consumables and reagents, services, and other related components. The technique finds usage in academic research institutes, clinical research institutes, hospitals and clinics, pharmaceuticals and biotechnology companies, among others.

The chromatin immunoprecipitation (ChIP) sequencing market research report is one of a series of new reports from The Business Research Company that provides chromatin immunoprecipitation (ChIP) sequencing market statistics, including chromatin immunoprecipitation (ChIP) sequencing industry global market size, regional shares, competitors with a chromatin immunoprecipitation (ChIP) sequencing market share, detailed chromatin immunoprecipitation (ChIP) sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the chromatin immunoprecipitation (ChIP) sequencing industry. This chromatin immunoprecipitation (ChIP) sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chip sequencing market size has grown rapidly in recent years. It will grow from $12.36 billion in 2023 to $13.89 billion in 2024 at a compound annual growth rate (CAGR) of 12.4%. The growth observed during the historical period can be attributed to advancements in understanding gene regulation, a rise in epigenetics studies, improvements in data analysis and bioinformatics tools, and the associated cost reduction and scalability in Chromatin Immunoprecipitation (ChIP) sequencing techniques.

The chip sequencing market size is expected to see rapid growth in the next few years. It will grow to $22.26 billion in 2028 at a compound annual growth rate (CAGR) of 12.5%. The anticipated growth in the forecast period can be attributed to increased industry investment and competition, growing clinical adoption for diagnostic applications, a demand for biomarker discovery, rapid development in bioinformatics tools, and expanded applications in drug discovery using Chromatin Immunoprecipitation (ChIP) sequencing. Major trends expected during the forecast period include the translation of ChIP sequencing into clinical and diagnostic applications, a heightened focus on histone modifications, application in novel research areas, advancements in sample preparation techniques, and the integration of multi-omics approaches.

The growth of the chromatin immunoprecipitation (ChIP) sequencing market is expected to be driven by the increasing prevalence of prostate cancer. Prostate cancer, which originates in the prostate gland, is anticipated to contribute to the market's expansion. ChIP-seq plays a vital role in prostate cancer research by providing a comprehensive understanding of the molecular events influencing the disease. This information is crucial for advancing the understanding of its biology and developing more targeted therapeutic interventions. In January 2023, the American Cancer Society reported an estimated 288,300 new cases of prostate cancer and 34,700 deaths in the US, emphasizing the significance of ChIP-seq in addressing this health concern.

The growth of the chromatin immunoprecipitation (ChIP) sequencing market is expected to be propelled by the increasing adoption of personalized medicine. Personalized medicine, which tailors medical decisions to individual patient characteristics, relies on identifying specific genetic or epigenetic markers associated with diseases. ChIP sequencing proves to be a powerful tool in mapping epigenetic modifications crucial for understanding the genetic basis of diseases. In 2022, the approval of 37 novel molecular entities by the FDA's Center for Drug Evaluation and Research, with 34% designated as tailored medications by the Personalized Medicine Coalition, highlights the role of ChIP sequencing in advancing personalized medicine.

The high cost of ChIP-sequencing technology is anticipated to hinder market growth. The substantial expenses associated with ChIP-Seq experiments, approximately $550 per sample, may limit the number of samples processed, slowing down research progress. This cost factor may impede the technology's adoption in therapeutic settings where cost-effectiveness is a critical consideration. While ChIP-Seq is considered more cost-effective than alternative methods, its expense, influenced by factors such as genome size and sequencing depth, remains a limiting factor for broader implementation.

Major companies in the chromatin immunoprecipitation (ChIP) sequencing market are addressing consumer needs through innovative products, such as molecular electronics chips. These chips, utilizing single molecules or molecular assemblies for electronic functions, aim to enhance research capabilities. For instance, Roswell Biotechnologies launched the Roswell ME Chip in November 2021, offering a flexible and potent tool for examining oligos and biological dynamics related to DNA and polymerase binding. This chip's potential applications extend across various industries, including fundamental science, environmental monitoring, and healthcare.

In August 2021, ProPhase Labs Inc., a US-based biotechnology company, acquired Nebula Genomics for $14.6 million. This strategic acquisition aligns with ProPhase's goal to better support individuals seeking assistance in diagnosing genetically impacted conditions. Nebula Genomics, known for its web service analyzing ChIP-sequencing (ChIP-Seq) data, contributes to ProPhase's commitment to advancing genetic diagnostics for various health concerns.

Major companies operating in the chromatin immunoprecipitation (chip) sequencing market report are F. Hoffmann La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc. , Becton Dickinson and Co., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc. , PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Bio-Techne Corp., BGI Genomics Co. Ltd., Promega Corporation, GenScript Biotech Corporation, Abcam plc, BioLegend Inc., Hamilton Co., Takara Bio Inc., Novogene Co. Ltd., Oxford Nanopore Technologies plc, Porvair Sciences Ltd. , Creative Biolabs Inc., Cell Signaling Technology Inc., GENEWIZ Inc., Zymo Research Corporation, CD Genomics, Active Motif Inc., Psomagen Inc., EpiCypher Inc.

North America was the largest region in the chromatin immunoprecipitation (ChIP) sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chromatin immunoprecipitation (chip) sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the chromatin immunoprecipitation (chip) sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The chromatin immunoprecipitation (ChIP) sequencing market consists of revenues earned by entities by providing services such as ChIP sample preparation, library preparation and sequencing, bioinformatics analysis, customization and consultation, data interpretation and reporting, and quality control, and assurance. The market value includes the value of related goods sold by the service provider or included within the service offering. The ChIP sequencing market also includes sales of ChIP kits, antibodies, DNA library preparation kits, sequencing kits, chromatin shearing equipment, and epigenetic modification kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chromatin immunoprecipitation (ChIP) Sequencing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chromatin immunoprecipitation (ChIP) sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chromatin immunoprecipitation (Chip) sequencing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chromatin immunoprecipitation (chip) sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: DNase-Sequencing; FAIRE-Sequencing
  • 2) By Technology: Targeted Sequencing And Re-Sequencing; Whole Genome Sequencing And Whole Exome Sequencing
  • 3) By Workflow: Pre-Sequencing; Sequencing; Data Analysis
  • 4) By Application: Consumables And Reagents; Service; Other Applications
  • 5) By End-User: Academic Research Institutes; Clinical Research Institutes; Hospitals And Clinics; Pharmaceuticals And Biotechnology Companies; Other End Users
  • Companies Mentioned: F. Hoffmann La Roche Ltd.; Merck KGaA; Thermo Fisher Scientific Inc. ; Becton Dickinson and Co.; Eurofins Scientific SE
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Chromatin Immunoprecipitation (ChIP) Sequencing Market Characteristics

3. Chromatin Immunoprecipitation (ChIP) Sequencing Market Trends And Strategies

4. Chromatin Immunoprecipitation (ChIP) Sequencing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market Size and Growth

  • 5.1. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Chromatin Immunoprecipitation (ChIP) Sequencing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Chromatin Immunoprecipitation (ChIP) Sequencing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Chromatin Immunoprecipitation (ChIP) Sequencing Market Segmentation

  • 6.1. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • DNase-Sequencing
  • FAIRE-Sequencing
  • 6.2. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Targeted Sequencing And Re-Sequencing
  • Whole Genome Sequencing And Whole Exome Sequencing
  • 6.3. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Workflow, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pre-Sequencing
  • Sequencing
  • Data Analysis
  • 6.4. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Consumables And Reagents
  • Service
  • Other Applications
  • 6.5. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Academic Research Institutes
  • Clinical Research Institutes
  • Hospitals And Clinics
  • Pharmaceuticals And Biotechnology Companies
  • Other End Users

7. Chromatin Immunoprecipitation (ChIP) Sequencing Market Regional And Country Analysis

  • 7.1. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 8.1. Asia-Pacific Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 9.1. China Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 9.2. China Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 10.1. India Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 11.1. Japan Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 11.2. Japan Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 12.1. Australia Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 13.1. Indonesia Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 14.1. South Korea Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 14.2. South Korea Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 15.1. Western Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 15.2. Western Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 16.1. UK Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 17.1. Germany Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 18.5. France Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 19.9. Italy Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 20.13. Spain Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 21.1. Eastern Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 21.2. Eastern Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 22.1. Russia Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 23.1. North America Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 23.2. North America Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 24.1. USA Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 24.2. USA Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 25.1. Canada Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 25.2. Canada Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 26.1. South America Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 26.2. South America Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 27.1. Brazil Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 28.1. Middle East Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 28.2. Middle East Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Chromatin Immunoprecipitation (ChIP) Sequencing Market

  • 29.1. Africa Chromatin Immunoprecipitation (ChIP) Sequencing Market Overview
  • 29.2. Africa Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Chromatin Immunoprecipitation (ChIP) Sequencing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Chromatin Immunoprecipitation (ChIP) Sequencing Market Competitive Landscape And Company Profiles

  • 30.1. Chromatin Immunoprecipitation (ChIP) Sequencing Market Competitive Landscape
  • 30.2. Chromatin Immunoprecipitation (ChIP) Sequencing Market Company Profiles
    • 30.2.1. F. Hoffmann La Roche Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merck KGaA
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Becton Dickinson and Co.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Eurofins Scientific SE
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Chromatin Immunoprecipitation (ChIP) Sequencing Market Other Major And Innovative Companies

  • 31.1. Agilent Technologies Inc.
  • 31.2. Illumina Inc.
  • 31.3. PerkinElmer Inc.
  • 31.4. Bio-Rad Laboratories Inc.
  • 31.5. Qiagen N.V.
  • 31.6. Bio-Techne Corp.
  • 31.7. BGI Genomics Co. Ltd.
  • 31.8. Promega Corporation
  • 31.9. GenScript Biotech Corporation
  • 31.10. Abcam plc
  • 31.11. BioLegend Inc.
  • 31.12. Hamilton Co.
  • 31.13. Takara Bio Inc.
  • 31.14. Novogene Co. Ltd.
  • 31.15. Oxford Nanopore Technologies plc

32. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market Competitive Benchmarking

33. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Chromatin Immunoprecipitation (ChIP) Sequencing Market

35. Chromatin Immunoprecipitation (ChIP) Sequencing Market Future Outlook and Potential Analysis

  • 35.1 Chromatin Immunoprecipitation (ChIP) Sequencing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Chromatin Immunoprecipitation (ChIP) Sequencing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Chromatin Immunoprecipitation (ChIP) Sequencing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer